英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
penna查看　penna　在百度字典中的解释百度英翻中〔查看〕
penna查看　penna　在Google字典中的解释Google英翻中〔查看〕
penna查看　penna　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Example of Wording for Letter of Authorization (LOA) For Individual . . .
    FDA is authorized to refer to [INSERT COMPANY’S NAME] IND [INSERT IND NUMBER] for the purpose of FDA’s review of the IND submitted by [INSERT PHYSICIAN SPONSOR’S NAME] and described above
  • Guidance for Industry: Providing Regulatory Submissions to CBER in . . .
    In this guidance, we discuss specific issues unique to the electronic submission of Investigational New Drug applications (INDs) and their amendments
  • What is a letter of authorization to cross reference IND?
    Learn what is a letter of authorization to cross reference IND, a key document in clinical research that allows the FDA to access proprietary drug data from another sponsor's application without breaching confidentiality
  • eCFR :: 21 CFR 20. 100 -- Applicability; cross-reference to other . . .
    § 20 100 Applicability; cross-reference to other regulations (a) The provisions set forth in this subpart or cross-referenced in paragraph (c) of this section state the way in which specific categories of Food and Drug Administration records are handled upon a request for public disclosure
  • IND Application Cross-Reference Guidance: Letter of Authorization
    The LOA must come from the sponsor holder Responsible Official of the IND, NDA or DMF referenced and must identify the file by name and IND number, be signed by the sponsor of the cross-referenced file and explicitly give FDA permission to reference that information submitted previously
  • Initial IND Application | Clinical Center
    If a sponsor is proposing to evaluate a drug that is the subject of an existing IND, they can request a letter of cross-reference authorization from the sponsor of that existing IND
  • IND Application Template:
    If the manufacturer of the investigational product provides a Letter of Authorization (LOA) to Cross Reference their full IND to include as an appendix in the application, for each of the following sections, reference to the appropriate appendix containing the LOA is all that is required
  • Preparing the Initial IND Application Submission
    For unmarketed drugs, the Investigator-Sponsor can request a Letter of Authorization (LOA) from the manufacturer to cross-reference the Drug Master File or existing IND if there is one Although it is not required, the LOA is recommended
  • Individual Patient IND Process Flow Guidelines from CHOP IND IDE . . .
    If the company requires the CHOP clinician to obtain authorization from the FDA and apply for an IND for Emergency Use, request a Letter of Authorization (LOA) from the medical product developer to treat the patient The LOA is typically from the regulatory affairs official of the industry (company) FDA may be able to help identify the contact
  • Letter of Authorization (LOA) - Pharma Topics
    An LOA is a formal document issued by a DMF holder that grants a regulatory agency (such as the FDA, EMA, MHRA, or TGA) permission to refer to the DMF in support of a drug application (e g , NDA, ANDA, IND, BLA, or MAA)





中文字典-英文字典  2005-2009